Phase-III Study of AJM300 in Patients with Active Ulcerative Colitis

Trial Profile

Phase-III Study of AJM300 in Patients with Active Ulcerative Colitis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Sep 2016

At a glance

  • Drugs Carotegrast (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Ajinomoto Pharma; EA Pharma
  • Most Recent Events

    • 22 Jun 2016 Status changed from active, no longer recruiting to recruiting.
    • 20 Jun 2016 Status changed from recruiting to active, no longer recruiting.
    • 09 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top